Therapeutic safety implications of SARM1 active site inhibitors: subinhibitory concentrations cause neurodegeneration.
Saved in:
| Title: | Therapeutic safety implications of SARM1 active site inhibitors: subinhibitory concentrations cause neurodegeneration. |
|---|---|
| Authors: | Leahey RR; Department of Neuroscience, Genentech, Inc., South San Francisco, CA, 94080, USA., Weber M; Department of Neuroscience, Genentech, Inc., South San Francisco, CA, 94080, USA., Cho CH; Department of Human Pathobiology and OMNI Reverse Translation, Genentech, Inc., South San Francisco, CA, 94080, USA., Hur SK; Department of Neuroscience, Genentech, Inc., South San Francisco, CA, 94080, USA., Cramer A; Department of Neuroscience, Genentech, Inc., South San Francisco, CA, 94080, USA., Manzanares K; Department of Biochemical and Cellular Pharmacology, Genentech, Inc., South San Francisco, CA, 94080, USA., Babin B; Department of Biochemical and Cellular Pharmacology, Genentech, Inc., South San Francisco, CA, 94080, USA., Boenig G; Department of Structural Biology, Genentech, Inc., South San Francisco, CA, 94080, USA., Kring T; Department of Pharmaceutics, Genentech, Inc., South San Francisco, CA, 94080, USA., Liu L; Department of Drug Metabolism & Pharmacokinetics, Genentech, Inc., South San Francisco, CA, 94080, USA., Cui Y; Department of Drug Metabolism & Pharmacokinetics, Genentech, Inc., South San Francisco, CA, 94080, USA., Ganti A; Department of Drug Metabolism & Pharmacokinetics, Genentech, Inc., South San Francisco, CA, 94080, USA., Evans JP; Arctoris Ltd, 120E Olympic Avenue, OX14 4SA, Abingdon, United Kingdom., Nespi M; Department of Pharmaceutics, Genentech, Inc., South San Francisco, CA, 94080, USA., Ly J; Department of Drug Metabolism & Pharmacokinetics, Genentech, Inc., South San Francisco, CA, 94080, USA., Nugent AA; Department of Human Pathobiology and OMNI Reverse Translation, Genentech, Inc., South San Francisco, CA, 94080, USA., Green SA; Department of Discovery Chemistry, Genentech, Inc., South San Francisco, CA, 94080, USA., Chan BK; Department of Discovery Chemistry, Genentech, Inc., South San Francisco, CA, 94080, USA., Hoogenraad CC; Department of Neuroscience, Genentech, Inc., South San Francisco, CA, 94080, USA., Delwig A; Department of Biochemical and Cellular Pharmacology, Genentech, Inc., South San Francisco, CA, 94080, USA. delwig.anton@gene.com., Hinz FI; Department of Neuroscience, Genentech, Inc., South San Francisco, CA, 94080, USA. hinz.flora@gene.com. |
| Source: | Npj drug discovery [NPJ Drug Discov] 2025 Aug 25; Vol. 2 (1). Date of Electronic Publication: 2025 Aug 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Portfolio Country of Publication: England NLM ID: 9918993695206676 Publication Model: Electronic Cited Medium: Internet ISSN: 3005-1452 (Electronic) Linking ISSN: 30051452 NLM ISO Abbreviation: NPJ Drug Discov Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42380237 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Therapeutic safety implications of SARM1 active site inhibitors: subinhibitory concentrations cause neurodegeneration. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Leahey+RR%22">Leahey RR</searchLink>; Department of Neuroscience, Genentech, Inc., South San Francisco, CA, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Weber+M%22">Weber M</searchLink>; Department of Neuroscience, Genentech, Inc., South San Francisco, CA, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Cho+CH%22">Cho CH</searchLink>; Department of Human Pathobiology and OMNI Reverse Translation, Genentech, Inc., South San Francisco, CA, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Hur+SK%22">Hur SK</searchLink>; Department of Neuroscience, Genentech, Inc., South San Francisco, CA, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Cramer+A%22">Cramer A</searchLink>; Department of Neuroscience, Genentech, Inc., South San Francisco, CA, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Manzanares+K%22">Manzanares K</searchLink>; Department of Biochemical and Cellular Pharmacology, Genentech, Inc., South San Francisco, CA, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Babin+B%22">Babin B</searchLink>; Department of Biochemical and Cellular Pharmacology, Genentech, Inc., South San Francisco, CA, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Boenig+G%22">Boenig G</searchLink>; Department of Structural Biology, Genentech, Inc., South San Francisco, CA, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Kring+T%22">Kring T</searchLink>; Department of Pharmaceutics, Genentech, Inc., South San Francisco, CA, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Liu+L%22">Liu L</searchLink>; Department of Drug Metabolism & Pharmacokinetics, Genentech, Inc., South San Francisco, CA, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Cui+Y%22">Cui Y</searchLink>; Department of Drug Metabolism & Pharmacokinetics, Genentech, Inc., South San Francisco, CA, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Ganti+A%22">Ganti A</searchLink>; Department of Drug Metabolism & Pharmacokinetics, Genentech, Inc., South San Francisco, CA, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Evans+JP%22">Evans JP</searchLink>; Arctoris Ltd, 120E Olympic Avenue, OX14 4SA, Abingdon, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Nespi+M%22">Nespi M</searchLink>; Department of Pharmaceutics, Genentech, Inc., South San Francisco, CA, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Ly+J%22">Ly J</searchLink>; Department of Drug Metabolism & Pharmacokinetics, Genentech, Inc., South San Francisco, CA, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Nugent+AA%22">Nugent AA</searchLink>; Department of Human Pathobiology and OMNI Reverse Translation, Genentech, Inc., South San Francisco, CA, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Green+SA%22">Green SA</searchLink>; Department of Discovery Chemistry, Genentech, Inc., South San Francisco, CA, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Chan+BK%22">Chan BK</searchLink>; Department of Discovery Chemistry, Genentech, Inc., South San Francisco, CA, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Hoogenraad+CC%22">Hoogenraad CC</searchLink>; Department of Neuroscience, Genentech, Inc., South San Francisco, CA, 94080, USA.<br /><searchLink fieldCode="AU" term="%22Delwig+A%22">Delwig A</searchLink>; Department of Biochemical and Cellular Pharmacology, Genentech, Inc., South San Francisco, CA, 94080, USA. delwig.anton@gene.com.<br /><searchLink fieldCode="AU" term="%22Hinz+FI%22">Hinz FI</searchLink>; Department of Neuroscience, Genentech, Inc., South San Francisco, CA, 94080, USA. hinz.flora@gene.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229918993695206676%22">Npj drug discovery</searchLink> [NPJ Drug Discov] 2025 Aug 25; Vol. 2 (1). <i>Date of Electronic Publication: </i>2025 Aug 25. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Portfolio%22">Nature Portfolio </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9918993695206676 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>3005-1452 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2230051452%22">30051452 </searchLink><i>NLM ISO Abbreviation: </i>NPJ Drug Discov <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42380237 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s44386-025-00023-4 Languages: – Code: eng Text: English Titles: – TitleFull: Therapeutic safety implications of SARM1 active site inhibitors: subinhibitory concentrations cause neurodegeneration. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Leahey RR – PersonEntity: Name: NameFull: Weber M – PersonEntity: Name: NameFull: Cho CH – PersonEntity: Name: NameFull: Hur SK – PersonEntity: Name: NameFull: Cramer A – PersonEntity: Name: NameFull: Manzanares K – PersonEntity: Name: NameFull: Babin B – PersonEntity: Name: NameFull: Boenig G – PersonEntity: Name: NameFull: Kring T – PersonEntity: Name: NameFull: Liu L – PersonEntity: Name: NameFull: Cui Y – PersonEntity: Name: NameFull: Ganti A – PersonEntity: Name: NameFull: Evans JP – PersonEntity: Name: NameFull: Nespi M – PersonEntity: Name: NameFull: Ly J – PersonEntity: Name: NameFull: Nugent AA – PersonEntity: Name: NameFull: Green SA – PersonEntity: Name: NameFull: Chan BK – PersonEntity: Name: NameFull: Hoogenraad CC – PersonEntity: Name: NameFull: Delwig A – PersonEntity: Name: NameFull: Hinz FI IsPartOfRelationships: – BibEntity: Dates: – D: 25 M: 08 Text: 2025 Aug 25 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 3005-1452 Numbering: – Type: volume Value: 2 – Type: issue Value: 1 Titles: – TitleFull: Npj drug discovery Type: main |
| ResultId | 1 |